Dr. Pollyea will utilize funding from this award to develop a program to systematically test leukemia stem-cell directed therapies.
Sign up for our patient focused digital newsletter, The Bloodline, which is published quarterly. The newsletter includes tips for patients, articles on self-care, a dietician approved recipe and information on what’s going on with our program.
A new program at the University of Colorado Cancer Center provides individual mentoring to patients and caregivers to provide additional support through the cancer journey. Meet Kaitlyn Cavanaugh, the Imerman Angels Program Ambassador for Colorado.
Join a group of moms training to run or walk a 10K or half marathon while raising money to help find a cure for blood cancers.
Find information about Cancer Support Groups in Colorado.
From her favorite part about her job to her favorite movie, our “Behind the Scrubs” interview with our new Post-Transplant Survivorship coordinator gives you a chance to get to know a little about Sarah Strozinski, RN, BSN, OCN and her role on our team.
Research tells us that when implementing any new goal for yourself, it is helpful to make your goal specific, obtainable, manageable, and relevant to you. You may be asking yourself “How do I go about making, and specifying, a goal for myself?”
In the featured article in the December issue of Nature Reviews Cancer, Dr. Graham describes the emerging field of TAM family kinases and their potential as therapeutic targets in leukemia and other forms of cancer.
Speaking at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Barcelona, Spain, Dr. Pollyea summarized the latest results for AG-120, an exciting new drug for the treatment of patients with advanced leukemia.
Israel has the highest BRCA+ prevalence of any nation. Rabinovitch will deliver lectures and collaborate with health professionals who have expertise with the BRCA+ population in Israel.
We are very pleased to announce that Dr. Manali Kamdar will be joining us in late November as a new attending physician and Assistant Professor in the Division of Hematology.
"If patients are having difficulties taking their medications, I want to provide the physicians with strategies to help their patients stay on schedule," says Brewer.
Read how the Blood Cancer program's Christine Frodella and other nurse navigators support patients at the University of Colorado Cancer Center
81-year-old Larry Rosenberg credits an experimental drug with saving his life from chronic lymphocytic leukemia. Now the Break Through Therapy Provision will help other patients get faster access to experimental drugs as well.
KCBO radio interview with our patient Emily about her experience with blood cancer. Her doctors treated her for an aggressive form of leukemia.